Loyens & Loeff hired Daniel Dedeyan (pictured) as a new partner. The addition is set to bolster the firm’s Banking & Finance practice. Dedeyan moves to Loyens & Loeff from a counsel position at
Tags :cn1
Loyens & Loeff advised alternative investment firm H.I.G. Capital in connection with its investment in German IT company Timetoact Group. The context Headquartered in Cologne, Timetoact specialises in cloud platforms and digital
Homburger advised the Swiss Shakti Foundation throughout establishment of its SXE Digital SMART Note Issuance Program.The notes issued under the SXE Digital SMART Note Issuance Program will be issued as ledger-based securities. The context
Homburger advises Idorsia Ltd on its holistic restructuring, which includes the revision of its outstanding convertible bonds totaling CHF 800 million and the raising of CHF 150 million through a new money facility. The context In connection
Real estate firm Swiss Prime Site successfully completed the placement of 2.9 m shares via an accelerated bookbuild offering. Homburger advised Swis Prime Site throughout the operation, while NKF represented Citigroup Global Markets Limited and UBS
Pestalozzi advised insurance company Swiss Life through its acquisition of Swiss advisory firm Zwei Wealth. The context Headquartered in Zurich, Swiss life is an insurance multinational, offering comprehensive life and pensions and financial solutions, directed
Niederer Kraft Frey (NKF) advised the shareholders of Swiss medical research institute IHZD on its sale to Affidea Group. The context IHZD, short for Institut für histologische und zytologische Diagnostik, operates two laboratories in
Niederer Kraft Frey (NKF) advised German tech investor Maguar through successful closing of a majority investment in Swiss Navori labs . The parties A specialist in B2B software investments, Maguar’s portfolio mostly comprehends small
Niederer Kraft Frey (NKF) advised Romer’s Holding, the parent company of Swiss frozen baked goods specialist Romer’s Hausbäckerei, on its acquisition of Kern & Sammet. The buyer is a group company of
Walder Wyss advised Danish life science investor Novo Holdings through its acquisition of American pharma multinational Catalent. Globally active in the fields of life sciences and healthcare, Novo Holdings acts as the only asset manager
